Browse studies

Find your next paid study

1 recruiting study matching your filters

An Open-label Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

The study is a phase II trial designed to evaluate the clinical efficacy, safety, and tolerability of MAS825 (arumakimig) in pediatric and adult participants w…

Still´s Disease

Estimated

~$10 – $8,750

Novartis PharmaceuticalsNCT07203001